CERo Therapeutics Holdings, Inc.
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell an…
Biotechnology
US, South San Francisco [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
CERo Therapeutics Holdings, Inc. can't present it's latest revenue by geo. area
Historical Revenue By Segment
Last 3Y, in mil. USDCERo Therapeutics Holdings, Inc. can't present revenue by segment